Literature DB >> 6397023

Biogenic amine regulation of glucagon secretion.

P Matsumoto, A Brown, J C Dunbar.   

Abstract

Norepinephrine, dopamine and serotonin directly stimulated glucagon secretion by isolated perifused hamster islet. Propranolol blocked norepinephrine, dopamine and serotonin-stimulated glucagon release, suggesting that norepinephrine, dopamine and serotonin may modulate glucagon secretion via a beta-adrenergic mechanism. Dopamine and serotonin may exert their action directly via the beta receptor, stimulate residual adrenergic nerve terminals, or the release of other islet biogenic amines. We conclude that part of the stimulating effect of norepinephrine on glucagon release is beta adrenergically mediated and that dopamine and serotonin may affect glucagon secretion either directly or through the release of neurotransmitters that lead to glucagon release. Thus the intra-islet released dopamine and serotonin may contribute to the islets paracrine system by stimulating intra-islet adrenergic neurons.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6397023     DOI: 10.1007/BF02582086

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  25 in total

1.  Inhibition of glucagon release by serotonin in mouse pancreatic islets.

Authors:  J Marco; J A Hedo; M L Villanueva
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

2.  Glucagon and insulin release. Influence of drugs affecting the autonomic nervous system.

Authors:  J E Vance; K D Buchanan; R H Williams
Journal:  Diabetes       Date:  1971-02       Impact factor: 9.461

3.  Studies on the secretion of pancreatic glucagon.

Authors:  T M Chesney; J G Schofield
Journal:  Diabetes       Date:  1969-09       Impact factor: 9.461

4.  Pancreatic biogenic amines and insulin secretion in health and disease.

Authors:  H E Lebovitz; J M Feldman
Journal:  Fed Proc       Date:  1973-07

5.  The occurrence of biogenic monoamines in the mammalian endocrine pancreas.

Authors:  L Cegrell
Journal:  Acta Physiol Scand Suppl       Date:  1968

6.  Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.

Authors:  M Lorenzi; J H Karam; E Tsalikian; N V Bohannon; J E Gerich; P H Forsham
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

7.  Effects of serotonin, of its biosynthetic precursors and of the anti-serotonin agent metergoline on the release of glucagon and insulin from rat pancreas.

Authors:  A E Pontiroli; P Micossi; P P Foá
Journal:  Horm Metab Res       Date:  1978-05       Impact factor: 2.936

8.  The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. II. Insulin responses to secretin and pancreozymin in experimentally-induced pancreatic exocrine insufficiency.

Authors:  R Goberna; R D Fussgänger; S Raptis; M Telib; E F Pfeiffer
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

9.  Effect of dopamine on human gastric and pancreatic secretion.

Authors:  J E Valenzuela; C Defilippi; G Diaz; E Navia; Y Merino
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

10.  The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. 3. Insulin responses to secretin and pancreozymin, and to oral and intravenous glucose, in patients suffering from chronic insufficiency of the exocrine pancreas.

Authors:  S Raptis; R M Rau; K E Schröder; W Hartmann; J D Faulhaber; P H Clodi; E F Pfeiffer
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.